InvestorsHub Logo
icon url

StonkMaster

12/26/23 12:48 PM

#659266 RE: biosectinvestor #659262

How does all brain tumors compare to just GBM wrt potential revenues/total cases.

Does anyone have those numbers handy?
icon url

antihama

12/26/23 7:44 PM

#659354 RE: biosectinvestor #659262

The PIM designation for DCVax-L covers all malignant gliomas, which would include both Glioblastoma multiforme (the most severe grade) as well as less malignant grades, and would include both newly diagnosed and recurrent gliomas.

The PIMS designation under EAMS (“Early Access to Medicines Scheme”) ship has sailed but you know what they say "where's there's smoke there's fire". https://www.sec.gov/Archives/edgar/data/1072379/000114420414056638/v389406_ex99-1.htm